Cohance Lifesciences shares rise after USFDA Form 483
Cohance Lifesciences shares rose nearly 5.5% on Monday, Sept. 21, after the USFDA issued a Form 483 with five observations from an inspection of the company’s Jaggaiahpet API manufacturing facility.